Structural determinants of selective thyromimetics

Journal of Medicinal Chemistry

Volumn 46, Issue 14, 2003, Pages 3152-3161

  Yoshihara, Hikari A I ^a   Apriletti, James W ^a   Baxter, John D ^a   Scanlan, Thomas S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' ISOPROPYL 3,5 DIMETHYLTHYRONINE; CGS 23425; CGS 26214; DRUG ANALOG; GC 1; THYROID HORMONE RECEPTOR; THYROMIMETIC AGENT; THYRONINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; RECEPTOR AFFINITY; STRUCTURE ANALYSIS;

ACETIC ACIDS; BINDING, COMPETITIVE; HUMANS; LIGANDS; PHENOLS; STRUCTURE-ACTIVITY RELATIONSHIP; THYROID HORMONE RECEPTORS BETA;

EID: 0038121691     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0301181     Document Type: Article

References (35)

1. Braverman, L. E.; Utiger, R. D.; Werner, S. C.; Ingbar, S. H. Werner and Ingbar's the Thyroid: a Fundamental and Clinical Text, 6th ed.; Lippincott: Philadelphia, PA, 1991; Chapter xxiii, p 1365.
2. Yen, P. M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 2001, 81, 1097-1142.
3. Lazar, M. A. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr. Rev. 1993, 14, 184-193.
4. Forrest, D.; Hanebuth, E.; Smeyne, R. J.; Everds, N.; Stewart, C. L.; et al. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function. EMBO J. 1996, 15, 3006-3015.
5. Forrest, D.; Erway, L. C.; Ng, L.; Altschuler, R.; Curran, T. Thyroid hormone receptor beta is essential for development of auditory function. Nat. Genet. 1996, 13, 354-357.
6. Fraichard, A.; Chassande, O.; Plateroti, M.; Roux, J. P.; Trouillas, J.; et al. The T3R alpha gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. EMBO J. 1997, 16, 4412-4420.
7. Gauthier, K.; Chassande, O.; Plateroti, M.; Roux, J. P.; Legrand, C.; et al. Different functions for the thyroid hormone receptors TRalpha and TRbeta in the control of thyroid hormone production and post-natal development. EMBO J. 1999, 18, 623-631.
8. Ng, L.; Hurley, J. B.; Dierks, B.; Srinivas, M.; Salto, C.; et al. A thyroid hormone receptor that is required for the development of green cone photoreceptors. Nat. Genet. 2001, 27, 94-98.
9. Chiellini, G.; Apriletti, J. W.; Yoshihara, H. A. I.; Baxter, J. D.; Ribeiro, R. C. J.; et al. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem. Biol. 1998, 5, 299-306.
10. Boyd, G. S.; Oliver, M. F. The effect of certain thyroxine analogues on the serum lipids in human subjects. J. Endocrinol. 1960, 21, 33-43.
11. Ballantyne, F. C.; Epenetos, A. A.; Caslake, M.; Forsythe, S.; Ballantyne, D. The composition of low-density lipoprotein and very-low-density lipoprotein subfractions in primary hypothyroidism and the effect of hormone-replacement therapy. Clin. Sci. (London) 1979, 57, 83-88.
12. Hansson, P.; Valdemarsson, S.; Nilssonehle, P. Experimental Hyperthyroidism in Man - Effects on Plasma-Lipoproteins, Lipoprotein-Lipase and Hepatic Lipase. Horm. Metab. Res. 1983, 15, 449-452.
13. Gomberg-Maitland, M.; Frishman, W. H. Thyroid hormone and cardiovascular disease. Am. Heart J. 1998, 135, 187-196.
14. Klein, I.; Ojamaa, K. Mechanisms of disease: thyroid hormone and the cardiovascular system. N. Engl. J. Med. 2001, 344, 501-509.
15. Wikstrom, L.; Johansson, C.; Salto, C.; Barlow, C.; Campos Barros, A.; et al. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1. EMBO J. 1998, 17, 455-461.
16. Schwartz, H. L.; Strait, K. A.; Ling, N. C.; Oppenheimer, J. H. Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity. J. Biol. Chem. 1992, 267, 11794-11799.
17. Gullberg, H.; Rudling, M.; Forrest, D.; Angelin, B.; Vennstrom, B. Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Mol. Endocrinol. 2000, 14, 1739-1749.
18. Taylor, A. H.; Stephan, Z. F.; Steele, R. E.; Wong, N. C. W. Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Mol. Pharmacol. 1997, 52, 542-547.
19. Stephan, Z. F.; Yurachek, E. C.; Sharif, R.; Wasvary, J. M.; Leonards, K. S.; et al. Demonstration of Potent Lipid-Lowering Activity by a Thyromimetic Agent Devoid of Cardiovascular and Thermogenic Effects. Atherosclerosis 1996, 126, 53-63.
20. Chiellini, G.; Nguyen, N. H.; Yoshihara, H. A. I.; Scanlan, T. S. Improved synthesis of the iodine-free thyromimetic GC-1. Bioorg. Med. Chem. Lett. 2000, 10, 2607-2611.
21. Jorgensen, E. C.; Murray, W. J.; Block, P., Jr. Thyroxine analogs. 22. Thyromimetic activity of halogen-free derivatives of 3,5-dimethyl-L-thyronine. J. Med. Chem. 1974, 17, 434-439.
22. Baxter, J. D.; Dillmann, W. H.; West, B. L.; Huber, R.; Furlow, J. D.; et al. Selective modulation of thyroid hormone receptor action. J. Steroid Biochem. Mol. Biol. 2001, 76, 31-42.
23. Trost, S. U.; Swanson, E.; Gloss, B.; Wang-Iverson, D. B.; Zhang, H. J.; et al. The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology 2000, 141, 3057-3064.
24. Morte, B.; Manzano, J.; Scanlan, T.; Vennstrom, B.; Bernal, J. Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 3985-3989.
25. Ribeiro, M. O.; Carvalho, S. D.; Schultz, J. J.; Chiellini, G.; Scanlan, T. S.; et al. Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific. J. Clin. Invest. 2001, 108, 97-105.
26. Koerner, D.; Schwartz, H. L.; Surks, M. I.; Oppenheimer, J. H. Binding of selected iodothyronine analogues to receptor sites of isolated rat hepatic nuclei. High correlation between structural requirements for nuclear binding and biological activity. J. Biol. Chem. 1975, 250, 6417-6423.
27. Wagner, R. L.; Apriletti, J. W.; McGrath, M. E.; West, B. L.; Baxter, J. D.; et al. A structural role for hormone in the thyroid hormone receptor. Nature 1995, 378, 690-697.
28. Wagner, R. L.; Huber, B. R.; Shiau, A. K.; Kelly, A.; Lima, S. T. C.; et al. Hormone selectivity in thyroid hormone receptors. Mol. Endocrinol. 2001, 15, 398-410.
29. Evans, D. A.; Katz, J. L.; West, T. R. Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine. Tetrahedron Lett. 1998, 39, 2937-2940.
30. Hansch, C.; Leo, A.; Hoekman, D. Exploring QSAR: Hydrophobic, Electronic, and Steric Constants; American Chemical Society: Washington, DC, 1995; p 384.
31. Darimont, B. D.; Wagner, R. L.; Apriletti, J. W.; Stallcup, M. R.; Kushner, P. J.; et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 1998, 12, 3343-3356.
32. Yoshihara, H. A. I.; Apriletti, J. W.; Baxter, J. D.; Scanlan, T. S. A designed antagonist of the thyroid hormone receptor. Bioorg. Med. Chem. Lett. 2001, 11, 2821-2825.
33. Chiellini, G.; Nguyen, N. H.; Apriletti, J. W.; Baxter, J. D.; Scanlan, T. S. Synthesis and biological activity of novel thyroid hormone analogues: 5′-aryl substituted GC-1 derivatives. Bioorg. Med. Chem. 2002, 10, 333-346.
34. Nguyen, N. H.; Apriletti, J. W.; Cunha Lima, S. T.; Webb, P.; Baxter, J. D.; et al. Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment. J. Med. Chem. 2002, 45, 3310-3320.
35. Apriletti, J. W.; Baxter, J. D.; Lau, K. H.; West, B. L. Expression of the rat alpha 1 thyroid hormone receptor ligand binding domain in Escherichia coli and the use of a ligand-induced conformation change as a method for its purification to homogeneity. Protein Expression Purif. 1995, 6, 363-370.